Compounds > avapro
Page last updated: 2024-10-29

avapro and Weight Loss

avapro has been researched along with Weight Loss in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Weight Loss: Decrease in existing BODY WEIGHT.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiao, P1
Gao, C1
Fan, J1
Du, H1
Long, Y1
Yin, Y1
Parhofer, KG1
Münzel, F1
Krekler, M1

Trials

1 trial available for avapro and Weight Loss

ArticleYear
Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.
    Cardiovascular diabetology, 2007, Nov-27, Volume: 6

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure

2007

Other Studies

1 other study available for avapro and Weight Loss

ArticleYear
Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties.
    Regulatory peptides, 2011, Aug-08, Volume: 169, Issue:1-3

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial F

2011